Acura Pharmaceuticals Inc. – Material Contracts Watch

EX-10.68

from 10-K 8 pages Amended, Consolidated and Restated Secured Promissory Note ​ November 10, 2022

12/34/56

EX-10.58

from 10-K 2 pages Amendment #3 to License, Development and Commercialization Agreement

12/34/56

EX-10.54

from 10-K 2 pages Article 2 Miscellanceous

12/34/56

EX-10.1

from S-8 8 pages 2021 Restricted Stock Unit Award Plan

12/34/56

EX-10.1

from 8-K 8 pages 2021 Restricted Stock Unit Award Plan

12/34/56

EX-10.53

from 10-K 3 pages Amendment to License, Development and Commercialization Agreement

12/34/56

EX-10.52

from 10-K 1 page Assignment of Promissory Note, Warrant and Security Agreement

12/34/56

EX-10.51

from 10-K 9 pages Common Stock Purchase Warrant

12/34/56

EX-10.50

from 10-K 38 pages License, Development and Commercialization Agreement

12/34/56

EX-10.49

from 10-Q 10 pages Amended, Consolidated and Restated Convertible Secured Promissory Note June 28, 2019

12/34/56

EX-10.48

from 10-Q 3 pages Promissory Note

12/34/56

EX-10.47

from 10-Q 3 pages Promissory Note

12/34/56

EX-10.46

from 10-Q 3 pages Promissory Note

12/34/56

EX-10.45

from 10-K 3 pages Promissory Note

12/34/56

EX-10.44

from 10-K 3 pages Promissory Note

12/34/56

EX-10.43

from 10-K 3 pages Promissory Note

12/34/56

EX-10.42

from 10-K 3 pages Promissory Note

12/34/56

EX-10.40

from 10-Q 3 pages Promissory Note

12/34/56

EX-10.39

from 10-Q 3 pages Promissory Note

12/34/56

EX-10.38

from 10-Q 3 pages Promissory Note

12/34/56